Video Experimental Relacionado
Updated: Jul 13, 2026
09:25
Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Asociación de CCR5 delta32 con riesgo reducido de asma
Lancet (London, England)
|October 16, 1999
Resumen
Las personas con la mutación CCR5 delta32 tienen un menor riesgo de desarrollar asma. Este hallazgo puede explicar la aparición común de esta variante genética en la población.
Área de la Ciencia:
- Inmunología Inmunología.
- Genética La genética.
- Medicina de las vías respiratorias.
Sus antecedentes:
- El receptor de quimiocinas C-C 5 (CCR5) juega un papel en las respuestas inmunes.
- La mutación CCR5 delta32 es una variante genética conocida que se encuentra en poblaciones humanas.
Objetivo del estudio:
- Para investigar la asociación entre la mutación CCR5 delta32 y el riesgo de asma.
- Explorar posibles explicaciones para la prevalencia de la mutación delta32 del CCR5.
Principales métodos:
- Análisis genético de individuos para la mutación CCR5 delta32.
- Evaluación epidemiológica de la prevalencia del asma en relación con el estado de la mutación.
Principales resultados:
- Se observó una reducción estadísticamente significativa en el riesgo de asma en individuos portadores de la mutación CCR5 delta32.
- Se identificó el efecto protector de la mutación contra el asma.
Conclusiones:
- La mutación CCR5 delta32 confiere un grado de protección contra el desarrollo del asma.
- Esta asociación protectora proporciona una posible explicación evolutiva para la prevalencia de la mutación.
Videos de Conceptos Relacionados
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:12Relative Risk
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...